Article Versions Notes

Ji J-H, Ahn SG, Yoo Y, Park S-Y, Kim J-H, Jeong J-Y, Park S, Lee I. Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer—The BRAIN Study. Cancers. 2024; 16(4):774. https://doi.org/10.3390/cancers16040774

Ji, Jung-Hwan, Sung Gwe Ahn, Youngbum Yoo, Shin-Young Park, Joo-Heung Kim, Ji-Yeong Jeong, Seho Park, and Ilkyun Lee. 2024. "Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer—The BRAIN Study" Cancers 16, no. 4: 774. https://doi.org/10.3390/cancers16040774

Ji, J.-H., Ahn, S. G., Yoo, Y., Park, S.-Y., Kim, J.-H., Jeong, J.-Y., Park, S., & Lee, I. (2024). Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer—The BRAIN Study. Cancers, 16(4), 774. https://doi.org/10.3390/cancers16040774